Literature DB >> 31388744

Corticosteroid-induced psychiatric disorders: genetic studies are needed.

Florence Thibaut1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31388744     DOI： 10.1007/s00406-019-01049-2

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN： 0940-1334            Impact factor:   5.270


× No keyword cloud information.
  10 in total

Review 1.  The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited.

Authors:  Amelia N Dubovsky; Sheila Arvikar; Theodore A Stern; Lloyd Axelrod
Journal:  Psychosomatics       Date:  2012 Mar-Apr       Impact factor: 2.386

Review 2.  Neuroactive steroids and PTSD treatment.

Authors:  Ann M Rasmusson; Christine E Marx; Suzanne L Pineles; Andrea Locci; Erica R Scioli-Salter; Yael I Nillni; Jennifer J Liang; Graziano Pinna
Journal:  Neurosci Lett       Date:  2017-02-12       Impact factor: 3.046

3.  Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis.

Authors:  Virginia Soria; Alexandre González-Rodríguez; Elena Huerta-Ramos; Judith Usall; Jesús Cobo; Miquel Bioque; Juan David Barbero; Clemente García-Rizo; Meritxell Tost; José Antonio Monreal; Javier Labad
Journal:  Psychoneuroendocrinology       Date:  2018-04-14       Impact factor: 4.905

4.  Depression and hypomania symptoms are associated with high dose corticosteroids treatment for MS relapses.

Authors:  Sarah Anne Morrow; Jennifer Barr; Heather Rosehart; Sandra Ulch
Journal:  J Affect Disord       Date:  2015-08-21       Impact factor: 4.839

5.  Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature.

Authors:  D A Lewis; R E Smith
Journal:  J Affect Disord       Date:  1983-11       Impact factor: 4.839

6.  Effects of antipsychotics on cortisol, interleukin-6 and hippocampal perfusion in healthy volunteers.

Authors:  Rowena Handley; Valeria Mondelli; Fernando Zelaya; Tiago Marques; Heather Taylor; Antje A T S Reinders; Christopher Chaddock; Grant McQueen; Kathryn Hubbard; Andrew Papadopoulos; Steve Williams; Philip McGuire; Carmine Pariante; Paola Dazzan
Journal:  Schizophr Res       Date:  2016-04-22       Impact factor: 4.939

7.  Prednisone effects on neurochemistry and behavior. Preliminary findings.

Authors:  O M Wolkowitz; D Rubinow; A R Doran; A Breier; W H Berrettini; M A Kling; D Pickar
Journal:  Arch Gen Psychiatry       Date:  1990-10

8.  A randomized, double-blind, placebo-controlled trial of lamotrigine for prescription corticosteroid effects on the human hippocampus.

Authors:  E Sherwood Brown; Nasreen Sayed; Changho Choi; Nicholas Tustison; Jared Roberts; Michael A Yassa; Erin Van Enkevort; Alyson Nakamura; Elena I Ivleva; Prabha Sunderajan; David A Khan; Miguel Vazquez; Bruce McEwen; Alexandra Kulikova; Alan B Frol; Traci Holmes
Journal:  Eur Neuropsychopharmacol       Date:  2019-01-03       Impact factor: 5.415

9.  HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.

Authors:  J Keller; R Gomez; G Williams; A Lembke; L Lazzeroni; G M Murphy; A F Schatzberg
Journal:  Mol Psychiatry       Date:  2016-08-16       Impact factor: 15.992

Review 10.  Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome.

Authors:  Anne M Schijvens; Rob Ter Heine; Saskia N de Wildt; Michiel F Schreuder
Journal:  Pediatr Nephrol       Date:  2018-03-16       Impact factor: 3.714
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.